n n n n n n n n
n Molecular Diagnostics,
n n
8th Edition by Nader Rifai, PhD
n n n n n n
Chapters 1 - 49
n n n n
,Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics 8th Edition Test Bank
n n n n n n n n
n
n n
Table of contents:
n n
I. Principles Of Laboratory Medicine
n n n n
Chapter 1. Clinical Chemistry, Molecular Diagnostics, and Laboratory Medicine
n n n n n n n n
Chapter 2. Selection and Analytical Evaluation of Methods — With Statistical Techniques
n n n n n n n n n n n
Chapter 3. Clinical Evaluation of Methods
n n n n n
Chapter 4. Evidence-Based Laboratory Medicine
n n n n
Chapter 5. Establishment and Use of Reference Values
n n n n n n n
Chapter 6. Specimen Collection, Processing, and Other Preanalytical Variables
n n n n n n n n
Chapter 7. Quality Management
n n n
II. Analytical Techniques And Instrumentation
n n n n
Chapter 8. Principles of Basic Techniques and Laboratory Safety
n n n n n n n n
Chapter 9. Optical Techniques
n n n
Chapter 10. Electrochemistry and Chemical Sensors
n n n n n
Chapter 11. Electrophoresis
n n
Chapter 12. Chromatography
n n
Chapter 13. Mass Spectrometry
n n n
Chapter 14. Enzyme and Rate Analyses
n n n n n
Chapter 15. Immunochemical Techniques
n n n
Chapter 16 Automationn n
Chapter 17. Point-of-Care Instrumentation
n n n
III. Analytesn
Chapter 18. Amino Acids, Peptides, and Proteins
n n n n n n
Chapter 19. Serum Enzymes
n n n
Chapter 20. Tumor Markers and Cancer Genes
n n n n n n
Chapter 21. Kidney Function Tests — Creatinine, GFR, Urea, and Uric Acid
n n n n n n n n n n n
Chapter 22. Carbohydrates
n n
Chapter 23. Lipids, Lipoproteins, Apolipoproteins, and Other Cardiac Risk Factors
n n n n n n n n n
Chapter 24. Electrolytes and Blood Gases
n n n n n
Chapter 25. Hormones n n
Chapter 26. Catecholamines and Serotonin
n n n n
Chapter 27. Vitamins, Trace Elements, Nutritional Assessment
n n n n n n
Chapter 28. Hemoglobin, Iron, and Bilirubin
n n n n n
Chapter 29. Porphyrins and Porphyrias
n n n n
Chapter 30. Therapeutic Drugs and Their Management
n n n n n n
Chapter 31. Clinical Toxicology
n n n
Chapter 32. Toxic Metals
n n n
IV. Pathophysiology
n
Chapter 33. Diabetes n n
,Chapter 34. Cardiovascular Disease
n n n
Chapter 35. Kidney Disease
n n n
Chapter 36. Physiology and Disorders of Water, Electrolyte, and Acid-Base Metabolism
n n n n n n n n n n
Chapter 37. Liver Disease
n nn n
Chapter 38. Gastrointestinal and Pancreatic Diseases
n n n n n
Chapter 39. Disorders of Bone and Mineral Metabolism
n nn n n n n n
Chapter 40. Disorders of the Pituitary Gland
n nn n n n n
Chapter 41. Disorders of the Adrenal Cortex
n n n n n n
Chapter 42. Thyroid Disorders
n n n
Chapter 43. Reproduction-Related Disorders
n n n
Chapter 44. Pregnancy and Prenatal Testing
n nn n n n
Chapter 45. Newborn Screening and Inborn Errors of Metabolism
n n n n n n n n
Chapter 46. Pharmacogenetics
n n
V. Molecular Diagnostics
n n
Chapter 47. Principles of Molecular Biology
n n n n n
Chapter 48. Nucleic Acid Techniques and Applications
n n n n n n
Chapter 49. Genomes and Nucleic Acid Alterations
n n n n n n
, Chapter 01: Clinical Chemistry, Molecular Diagnostics, and Laboratory Medicine Test
n n n n n n n n n
Bank
n
MULTIPLE CHOICE n
1. An individual working in a clinical chemistry laboratory is married to a sales representative who
n n n n n n n n n n n n n n
works for a company that sells chemistry laboratory supplies. When the laboratory manager
n n n n n n n n n n n n n
requests a list of needed supplies, cost of supplies, and vendors, this individual onlyrecommends
n n n n n n n n n n n n n n n
the spouse’s company as the vendor. This is considered to be a(n):
n n n n n n n n n n n n
a. accounting issue. n
b. possible conflict of interest. n n n
c. maintenance of confidentiality issue. n n n
d. problem with resource allocation. n n n
ANS: B n
Concern has been raised over the interrelationships between practitioners in the medical fieldand
n n n n n n n n n n n n n
commercial suppliers of drugs, devices, equipment, etc., to the medical profession.
n n n n n n n n n n n
Similarly, relationships have been scrutinized between clinical laboratorians and manufacturers
n n n n n n n n n
and providers of diagnostic equipment and supplies. These concerns led the National Institutes of
n n n n n n n n n n n n n n
Health (NIH) in 1995 to require official institutional review of financial disclosure by researchers
n n n n n n n n n n n n n n
and management of situations in which disclosure indicates potentialconflicts of interest.
n n n n n n n n n n n n
DIF: 1 REF: Page 4-5 nnn n OBJ: 6 |7 n n n
2. A patient visits her physician stating that her prescribed painkiller is not working to reduce the
n n n n n n n n n n n n n n n
pain following her recent surgery. A friend of the patient claims that the same painkiller
n n n n n n n n n n n n n n n
“worked wonders” to reduce her pain after the same surgery. The physician states that the
n n n n n n n n n n n n n n n
difference in the effect of the drug might be caused by
n , which is studied in
n n n n n n n n n n n n n n
pharmacogenetics.
n
a. epidemiology
b. an inherited disease n n
c. a conflict of interest n n n
d. a genetic variation in drug-metabolizing enzymes
n n n n n
ANS: D n
Pharmacogenetics is the study of the genetic variation of drug metabolism between n n n n n n n n n n n
individuals.
n
DIF: 1 REF: Page 3 nnn n OBJ: 1 n
3. John works in a molecular diagnostics laboratory and receives a blood sample that has the name
n n n n n n n n n n n n n n n
of a close friend printed on the bar-coded label. The genetic test that is ordered on thefriend’s
n n n n n n n n n n n n n n n n n n
sample would provide diagnostic information about a disorder that has a poor prognosis, and
n n n n n n n n n n n n n n
the test is usually performed by John. He asks a fellow employee to analyzethe sample for him
n n n n n n n n n n n n n n n n n n
and not divulge the results. This ethical issue concerns:
n n n n n n n n n
a. confidentiality of patient genetic and medical information. n n n n n n
b. a conflict of interest. n n n
c. resource allocation. n
d. diagnostic accuracy. n